You’re three weeks into evaluating a new inference platform. The pricing page looks reasonable, the docs are decent, the benchmarks hold up in your own tests. Then you check who funded the company’s last raise, and who’s underwriting the data center their capacity depends on, and who sold them every accelerator in the rack. Same name, three times. You close the tab and stare at it for a second.
That moment is happening a lot lately, and it’s why I’ve started reading cap tables alongside API docs.
What the “central bank” framing actually means
Through 2026, a pile of outlets landed on the same metaphor almost simultaneously. The Economist ran with it on September 3rd. Reuters used a softer version. Seeking Alpha went with “Federal Reserve of AI” back in August. The Financial Times framed it as a crown that could slip. When that many desks reach for the same comparison in the same season, they’re usually describing something real that doesn’t have a proper name yet.
The substance: Nvidia isn’t just selling hardware into AI infrastructure projects. It’s providing significant financial support and loans to them. It’s the supplier and, increasingly, the lender. Analysts project revenue could reach $1 trillion by 2029. Critics are worried about what this does to the debt market, and that worry isn’t abstract hand-wringing about valuations. It’s about what happens when the entity extending credit to buyers is also the entity booking the sale.
One detail from the reporting stuck with me more than the numbers: Nvidia’s potential backstop of these deals points at a weak spot in the industry, which is the poor financial shape of AI model companies and the real possibility they can’t pay. That’s the part that matters for anyone choosing tools. Not the trillion-dollar headline. The part where the companies building the products you’re evaluating may not be able to cover their own compute bills without help from the company selling them the compute.
Why a tools reviewer cares about macro plumbing
My job is to tell you whether something works. Normally that means latency, error rates, whether the SDK fights you, whether support answers. Financial structure felt like someone else’s beat.
It isn’t anymore, because pricing is downstream of capital. When credit is cheap and flowing from a supplier with an interest in keeping buyers buying, you get generous free tiers, aggressive per-token pricing, and startups that can eat a loss on your account for two years. That’s genuinely nice while it lasts. It also means the price you’re evaluating may not be a price. It may be a subsidy with a shelf life.
I’ve watched enough tools go from beloved to deprecated to know how this ends when the money tightens. Usually not with a shutdown notice. Usually with:
- A pricing page that quietly gains a new tier above yours
- Rate limits that appear where none existed
- The free tier becoming a trial
- An acquisition, then a sunset email eighteen months later
None of that is unique to AI. What’s different is the concentration. Thirty years to a $1 trillion valuation, then nine more months to $2 trillion, and now that same company sits underneath most of the tools I test. In a normal market you’d hedge by picking vendors with different suppliers. Right now, most of them share one.
What I’m doing about it
Nothing dramatic. I’m not telling anyone to avoid AI tooling because of debt market structure, which would be silly advice. I’ve just added a few questions to how I evaluate things.
Portability first. If I can move a workload between providers with a config change, vendor financial health drops from existential to annoying. If migration means rewriting prompt logic, rebuilding evals, and retraining a team, I want to know that before I commit, not after.
Then: does this company have revenue, or does it have funding? Both are fine. They are not the same thing, and only one survives a credit squeeze. Founders will usually tell you if you ask directly.
Then: how weird is the pricing? Not “is it cheap,” but “is it cheap in a way that doesn’t make sense.” Unlimited anything at $20 a month is a bet on future costs falling or future capital arriving. Sometimes that bet pays off. Sometimes you’re the one holding the integration when it doesn’t.
The tools I review are, mostly, good. Better than a year ago, cheaper, faster. That’s real, and I’d rather say so than perform skepticism. But the reason they’re cheap is partly that someone very large has an interest in keeping the whole thing moving, and that someone is a chip company acting like a lender. Worth knowing when you pick what to build on.
🕒 Published: